J-Valve Transfemoral Pivotal Study
A trial with no phase registered on ClinicalTrials.gov. The registry status is active, not recruiting. It plans to enroll 194 participants.
Also called NCT06455787
- Study
- In this atlas
Overview
- Design
- Interventional study; allocation not applicable; no masking; primary purpose treatment
- Phase
- Not applicable
- Enrolled
- 194 participants
- Registry
-
NCT06455787
-
- Started
- (actual)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- United States, Canada, France, Japan, United Kingdom
- Registry status
- Active, not recruiting
Technical summary
Registry record NCT06455787. Allocation not applicable; no masking; primary purpose treatment. Start 2024-10-17 (actual); primary completion 2028-02 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- J-Valve Transfemoral Pivotal Study
- Acronym
- JOURNEY
- Condition
- Aortic Valve Regurgitation
- Condition
- Aortic Valve Disease Mixed
- Intervention (Device)
- J-Valve Transfemoral (TF) System
- Lead sponsor
- JC Medical, Inc., an affiliate of Edwards Lifesciences LLC
- Collaborator
- Minneapolis Heart Institute Foundation
- Collaborator
- Cardiovascular Research Foundation, New York
Record details
- Record id
cardio:ct-nct06455787- Content hash
25722b7a09c9c35c2c8f2aa3ddfaa6d2d0d679516eddbb16c9568abfaf388f28